View Single Comment
See our disclaimer here.
See our disclaimer here.
November 20th, 2014 2:41 pm
Courtesy of Doug Short.
The Consumer Price Index for Urban Consumers (CPI-U) released this morning puts the October year-over-year inflation rate at 1.66%, off the May 19-month high of 2.13%. It is well below the 3.86% average since the end of the Second World War and 29 percent below its 10-year moving average.
For a comparison of headline inflation with core inflation, which is based on the CPI excluding food and energy, see this monthly feature.
For better understanding of how CPI is measured and how it impacts your household, see my Inside Look at CPI components.
For an even closer look at how the components are behaving, see this X-Ray View of the data for the past six months.
The Bureau of Labor Statistics (BLS) has compiled CPI dat...
November 20th, 2014 2:40 pm
Submitted by Tyler Durden.
Two months ago, to much fanfare by the progressive community, HHS, if not Dr. Jonathan Gruber, were delighted to report that as of August 15, Obamacare enrolment had hit 7.3 million sign ups, well above the 7.0 million goal.
7.3 million people were signed up for Obamacare as of Aug 15 and paid their premiums, HHS says
— igorvolsky (@igorvolsky) September 18, 2014
Then a week ago we learned that "projection mistakes were made" after the ...
November 20th, 2014 1:40 pm
Reminder: David is available to chat with Members, comments are found below each post.
November 20th, 2014 10:15 am
Courtesy of Pam Martens.
Depending on where and when you got your news yesterday on the tragic death of Shawn D. Miller, a Managing Director of Wall Street mega bank, Citigroup, you were either emphatically told he died of a suicide or you were led to believe he was murdered. By late evening yesterday, the story had disintegrated into wild speculation. The New York Daily News ran this stunning headline, based on anonymous sources, at 9:22 p.m.: “Banker, 42, slashed his own throat in Manhattan bathtub during drug- and booze-filled bender: sources.”
It is becoming abundantly clear that if you work for a major Wall Street firm and die a sudden death, it will be shaped, molded, twisted and contorted until it fits with the suicide narrative – no matter how ...
November 19th, 2014 11:00 pm
Courtesy of Benzinga.Related HAE Events for the Week of Nov. 17-21, 2014 Midday Losers From November 3: RCS Capital, Haemonetics, Granite Construction And More
In a report published Thursday, Barrington Research analyst Michael Petusky assumed coverage on Haemonetics Corporation (NYSE: HAE) with an Outperform rating and $46.00 price target.
In the report, Barrington Research noted, “Our price target is $46 and we arrive at our target by attaching a ...
November 19th, 2014 5:00 pmEZCH - Not So EZ Year
After a disappointing quarter and some probable tax-selling, EZchip might be a good turnaround for next year.
So I'm thinking we'll sell a stock or two out of Paul's otherwise neglected Virtual Portfolio (check back) and add EZCH....
November 17th, 2014 9:53 am
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...
November 17th, 2014 7:59 am
Reminder: Sabrient is available to chat with Members, comments are found below each post.
Courtesy of Sabrient Systems and Gradient Analytics
By Scott Martindale
Investors in U.S. equities seem to have embraced a new market paradigm in which upside spikes come more swiftly than the downside selloffs. Remember when it used to be the other way around? When fear was stronger than greed? The market is consolidating its gains off the early-October V-bottom reversal, and no one seems to be in any hurry to unload shares this time around, with the holidays rapidly approaching and all. After all, there are bright blue skies directly overhead giving hope and respite from the early freeze blanketing the country.
In this weekly update, I give my view of the current market environment, offer...
November 16th, 2014 2:01 am
Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.
The newest Stock World Weekly is ready. Click here for the this weekend's reading and sign in with your PSW user name and password.
Picture credit: AnnaER at Pixabay....
November 10th, 2014 8:59 am
If you would have supposed that Ukraine had enough problems to make banning bitcoins a backburner issue, you'd have been wrong. The rationale, "to protect consumers' rights" makes little to no sense... The other one, "to keep money in the country" makes more sense.Ukraine Central Bank Bans Bitcoin "To Protect Citizens" From Financing Terrorism
The Hryvnia has collapsed to new record lows near 15/USD this morning. The Central Bank and bankers "agreed to keep UAH at 15-16/USD" but are &qu...
November 5th, 2014 10:08 pmYamana Gold call options sink
By Andrew Wilkinson at Interactive Brokers
A four-year low for the spot price of gold has had a devastating impact on Yamana Gold (Ticker: AUY), with shares in the name down at the lowest price in six years. Some option traders were especially keen to sell premium and appear to see few signs of a lasting rebound within the next five months. The price of gold suffered again Wednesday as the dollar strengthened and stock prices advanced. The post price of gold fell to $1145 adding further pain to share prices of gold miners. Shares in Yamana Gold tumbled to $3.62 and the lowest price since 2008 as call option sellers used the April expiration contract to write premium at the $5.00 strike. That strike is now 38% above the price of the stock. Premium writers took in around 16-cents per contract o...
October 30th, 2014 4:56 pm
June 3rd, 2014 3:37 pm
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well PSW Subscribers....I am still here, barely. From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.
First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices. Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment. Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer. For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...
May 22nd, 2014 5:03 pm
"Hello PSW Members –
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at email@example.com with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
Thank you for you time!
Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...